Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07265323 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition

Study acronym: MIND-IT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this clinical trial is to determine if a weekly delivery of insulin at short intervals lasting up to 2 hours can improve insulin sensitivity and cognition in adults with Alzheimer's Disease. It will also provide information about the safety and feasibility of this intervention. The main questions it aims to answer are: Does the intervention improve insulin sensitivity (how the body uses glucose)? Does the intervention improve cognition, measured by the Montreal Cognitive Assessment (MoCA) and the Revised Memory and Behavior Problems Checklist (RMBPC)? What changes occur in brain glucose uptake (FDG-PET)? Participants will: Receive the intervention once a week for 6 months, with each session lasting up to 2 hours Complete cognitive assessments. Adverse events will be assessed throughout the study.
Trial Details
NCT Number NCT07265323
Lead Sponsor Pennington Biomedical Research Center
Conditions
(from sponsor)		 Alzheimer s Disease, Alzheimer Blood Biomarkers, Insulin Sensitivity
Related terms Alzheimer Disease, Insulin Resistance
Enrollment 8 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov